Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor–Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst formation and variable renal function decline that frequently leads to end-stage renal failure. With the advent of renoprotective treatment, there is renewed interest in noninvasive biomarkers to...
Main Authors: | Shosha E.I. Dekker, L. Renee Ruhaak, Fred P.H.T.M. Romijn, Esther Meijer, Christa M. Cobbaert, Johan W. de Fijter, Darius Soonawala, Joost P.H. Drenth, Ron T. Gansevoort, Dorien J.M. Peters, Jack F. Wetzels, Robert Zietse |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024919301160 |
Similar Items
-
Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case series
by: Bernts, LHP, et al.
Published: (2020) -
Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post−Myocardial Infarction Patients: The Alpha Omega Cohort Study
by: Kevin Esmeijer, et al.
Published: (2018-07-01) -
Abdominal Imaging in ADPKD: Beyond Total Kidney Volume
by: Anna Caroli, et al.
Published: (2023-08-01) -
Congenital Hepatic Fibrosis as an Early Sign of Presentation of ADPKD
by: Sila L., et al.
Published: (2022-12-01) -
Targeting the ADPKD methylome using nanoparticle-mediated combination therapy
by: Annie Trinh, et al.
Published: (2023-06-01)